MG53, mitsugumin (or Tripartite motif containing 72, TRIM72)
The product was removed from refrigerated storage for an extended period of time.Recall Initiation Date: April 9, 2025Link: FDA Enforcement Report Facility Inspections FDA Warning Letters ProRx, LLC Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: January 15, 2025Facility Location: Exton, PennsylvaniaInspection Dates: July 15, 2024, to August 2, 2024
doi: 10.1002/ijc.32270 305 SiroisIAguilar-MahechaALafleurJFowlerEVuVScriverMet al
Approaches like chemical peels, laser therapy, or topical lightening agents are designed for keratinized skin, not oral mucosa
GLP-1: Surging costs a concern Tired of that endless cycle, Childs doctors at UMass Memorial Health recommended he try a class of drugs known as GLP-1
One condition concerns the bulk drug substance used to prepare the medication